|
|
Volumn 32, Issue 17, 2014, Pages 1851-1852
|
|
Is there any benefit from hypofractionation in external-beam irradiation for prostate cancer?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
PROSTATE SPECIFIC ANTIGEN;
BIOCHEMICAL RECURRENCE FREE SURVIVAL;
CANCER RADIOTHERAPY;
CANCER RISK;
CANCER SURVIVAL;
CYBERKNIFE;
DISEASE FREE SURVIVAL;
EXTERNAL BEAM RADIOTHERAPY;
FOLLOW UP;
GASTROINTESTINAL TOXICITY;
GLEASON SCORE;
HIGH RISK PATIENT;
HUMAN;
INTENSITY MODULATED RADIATION THERAPY;
INTERMEDIATE RISK PATIENT;
LETTER;
MALE;
MORBIDITY;
NEPHROTOXICITY;
PHASE 2 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PROSTATE CANCER;
RADIATION DOSE FRACTIONATION;
STEREOTACTIC BODY RADIATION THERAPY;
THERAPY EFFECT;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
RADIOTHERAPY, INTENSITY-MODULATED;
|
|
EID: 84905858521
PISSN: 0732183X
EISSN: 15277755
Source Type: Journal
DOI: 10.1200/JCO.2013.54.4247 Document Type: Letter |
|
Times cited : (5)
|
|
References (5)
|
